APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Vaccine for Men(Male HPV Vaccine)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global HPV Vaccine for Men(Male HPV Vaccine) Market Outlook and Growth Opportunities 2026

26 December 2025194 pages

Choose your research edition.

Industry ResearchHPV Vaccine for Men(Male HPV Vaccine) Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Vaccine for Men(Male HPV Vaccine) Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal HPV Vaccine for Men(Male HPV Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Vaccine for Men(Male HPV Vaccine) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Vaccine for Men(Male HPV Vaccine) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global HPV Vaccine for Men(Male HPV Vaccine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the HPV Vaccine for Men(Male HPV Vaccine) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the HPV Vaccine for Men(Male HPV Vaccine) market include Bovaxbio, Kangle Guardian, Merck and Wantai Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global HPV Vaccine for Men(Male HPV Vaccine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HPV Vaccine for Men(Male HPV Vaccine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HPV Vaccine for Men(Male HPV Vaccine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HPV Vaccine for Men(Male HPV Vaccine) market size, projected growth trends, production technologies, key applications, and end-use industries.

HPV Vaccine for Men(Male HPV Vaccine) Segment by Company

Bovaxbio

Kangle Guardian

Merck

Wantai Biotech

HPV Vaccine for Men(Male HPV Vaccine) Segment by Type

Domestic

Imported

HPV Vaccine for Men(Male HPV Vaccine) Segment by Application

Penile Cancer and Precancerous Lesions

Genital Warts

Perineal Cancer and Precancerous Lesions

Perianal Cancer and Precancerous Lesions

Others

HPV Vaccine for Men(Male HPV Vaccine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global HPV Vaccine for Men(Male HPV Vaccine) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions HPV Vaccine for Men(Male HPV Vaccine) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify HPV Vaccine for Men(Male HPV Vaccine) significant trends, drivers, influence factors in global and regions.

6. To analyze HPV Vaccine for Men(Male HPV Vaccine) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccine for Men(Male HPV Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccine for Men(Male HPV Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccine for Men(Male HPV Vaccine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the HPV Vaccine for Men(Male HPV Vaccine) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HPV Vaccine for Men(Male HPV Vaccine) industry.

Chapter 3: Detailed analysis of HPV Vaccine for Men(Male HPV Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of HPV Vaccine for Men(Male HPV Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of HPV Vaccine for Men(Male HPV Vaccine) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. HPV Vaccine for Men(Male HPV Vaccine) Industry Trends Table 2. HPV Vaccine for Men(Male HPV Vaccine) Industry Drivers Table 3. HPV Vaccine for Men(Male HPV Vaccine) Industry Opportunities and Challenges Table 4. HPV Vaccine for Men(Male HPV Vaccine) Industry Restraints Table 5. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Company (2021-2026) Table 7. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Company (2021-2026) Table 9. Global HPV Vaccine for Men(Male HPV Vaccine) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global HPV Vaccine for Men(Male HPV Vaccine) Company Ranking, (2024-2026) & (USD Million) Table 11. Global HPV Vaccine for Men(Male HPV Vaccine) Key Company Manufacturing Base & Headquarters Table 12. Global HPV Vaccine for Men(Male HPV Vaccine) Company, Product Type & Application Table 13. Global HPV Vaccine for Men(Male HPV Vaccine) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global HPV Vaccine for Men(Male HPV Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Domestic Table 18. Significant Companies of Imported Table 19. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Type (2021-2026) Table 23. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Type (2027-2032) Table 24. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type (2021-2026) Table 28. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Penile Cancer and Precancerous Lesions Table 30. Significant Companies of Genital Warts Table 31. Significant Companies of Perineal Cancer and Precancerous Lesions Table 32. Significant Companies of Perianal Cancer and Precancerous Lesions Table 33. Significant Companies of Others Table 34. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application (2021-2026) & (K Units) Table 36. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application (2027-2032) & (K Units) Table 37. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Application (2021-2026) Table 38. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Application (2027-2032) Table 39. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application (2021-2026) Table 43. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application (2027-2032) Table 44. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2026) & (K Units) Table 46. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region (2021-2026) Table 47. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2027-2032) & (K Units) Table 48. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region (2027-2032) Table 49. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Region (2021-2026) Table 52. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Region (2027-2032) Table 54. Global HPV Vaccine for Men(Male HPV Vaccine) Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global HPV Vaccine for Men(Male HPV Vaccine) Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026) & (K Units) Table 59. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021-2026) Table 60. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2027-2032) & (K Units) Table 61. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2027-2032) Table 62. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Market Share by Country (2021-2026) Table 64. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Market Share by Country (2027-2032) Table 66. Bovaxbio Company Information Table 67. Bovaxbio Business Overview Table 68. Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 70. Bovaxbio Recent Development Table 71. Kangle Guardian Company Information Table 72. Kangle Guardian Business Overview Table 73. Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 75. Kangle Guardian Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 80. Merck Recent Development Table 81. Wantai Biotech Company Information Table 82. Wantai Biotech Business Overview Table 83. Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 85. Wantai Biotech Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. HPV Vaccine for Men(Male HPV Vaccine) Distributors List Table 89. HPV Vaccine for Men(Male HPV Vaccine) Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. HPV Vaccine for Men(Male HPV Vaccine) Product Image Figure 2. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 4. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (2021-2032) & (K Units) Figure 5. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global HPV Vaccine for Men(Male HPV Vaccine) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Domestic Image Figure 10. Imported Image Figure 11. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Type (2021-2032) Figure 14. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type (2021-2032) Figure 17. Penile Cancer and Precancerous Lesions Image Figure 18. Genital Warts Image Figure 19. Perineal Cancer and Precancerous Lesions Image Figure 20. Perianal Cancer and Precancerous Lesions Image Figure 21. Others Image Figure 22. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Application (2021-2032) Figure 25. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application (2021-2032) Figure 28. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 33. North America HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 39. South America HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. HPV Vaccine for Men(Male HPV Vaccine) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. HPV Vaccine for Men(Male HPV Vaccine) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Domestic
  • Imported
Applications
  • Penile Cancer and Precancerous Lesions
  • Genital Warts
  • Perineal Cancer and Precancerous Lesions
  • Perianal Cancer and Precancerous Lesions
  • Others
Companies covered
  • Bovaxbio
  • Kangle Guardian
  • Merck
  • Wantai Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032)
  4. 1.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume (2021-2032)
  5. 1.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 HPV Vaccine for Men(Male HPV Vaccine) Market Dynamics
  1. 2.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Trends
  2. 2.2 HPV Vaccine for Men(Male HPV Vaccine) Industry Drivers
  3. 2.3 HPV Vaccine for Men(Male HPV Vaccine) Industry Opportunities and Challenges
  4. 2.4 HPV Vaccine for Men(Male HPV Vaccine) Industry Restraints
3 HPV Vaccine for Men(Male HPV Vaccine) Market by Company
  1. 3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Company Revenue Ranking in 2025
  2. 3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Company (2021-2026)
  3. 3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Company (2021-2026)
  4. 3.4 Global HPV Vaccine for Men(Male HPV Vaccine) Average Price by Company (2021-2026)
  5. 3.5 Global HPV Vaccine for Men(Male HPV Vaccine) Company Ranking (2024-2026)
  6. 3.6 Global HPV Vaccine for Men(Male HPV Vaccine) Company Manufacturing Base and Headquarters
  7. 3.7 Global HPV Vaccine for Men(Male HPV Vaccine) Company Product Type and Application
  8. 3.8 Global HPV Vaccine for Men(Male HPV Vaccine) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 HPV Vaccine for Men(Male HPV Vaccine) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 HPV Vaccine for Men(Male HPV Vaccine) Market by Type
  1. 4.1 HPV Vaccine for Men(Male HPV Vaccine) Type Introduction
  2. 4.1.1 Domestic
  3. 4.1.2 Imported
  4. 4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type
  5. 4.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type
  9. 4.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Type (2021-2032)
  11. 4.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type (2021-2032)
5 HPV Vaccine for Men(Male HPV Vaccine) Market by Application
  1. 5.1 HPV Vaccine for Men(Male HPV Vaccine) Application Introduction
  2. 5.1.1 Penile Cancer and Precancerous Lesions
  3. 5.1.2 Genital Warts
  4. 5.1.3 Perineal Cancer and Precancerous Lesions
  5. 5.1.4 Perianal Cancer and Precancerous Lesions
  6. 5.1.5 Others
  7. 5.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application
  8. 5.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume by Application (2021-2032)
  10. 5.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Volume Share by Application (2021-2032)
  11. 5.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application
  12. 5.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Application (2021-2032)
  14. 5.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application (2021-2032)
6 HPV Vaccine for Men(Male HPV Vaccine) Regional Sales and Value Analysis
  1. 6.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2032)
  3. 6.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021-2026
  4. 6.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2027-2032)
  5. 6.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Region (2021-2032)
  7. 6.4.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Region: 2021-2026
  8. 6.4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Region (2027-2032)
  9. 6.5 Global HPV Vaccine for Men(Male HPV Vaccine) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032)
  12. 6.6.2 North America HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032)
  15. 6.7.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032)
  21. 6.9.2 South America HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Country, 2025 VS 2032
7 HPV Vaccine for Men(Male HPV Vaccine) Country-level Sales and Value Analysis
  1. 7.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
  4. 7.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026)
  5. 7.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2027-2032)
  6. 7.4 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country (2021-2032)
  7. 7.4.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country (2021-2026)
  8. 7.4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bovaxbio
  2. 8.1.1 Bovaxbio Company Information
  3. 8.1.2 Bovaxbio Business Overview
  4. 8.1.3 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  6. 8.1.5 Bovaxbio Recent Developments
  7. 8.2 Kangle Guardian
  8. 8.2.1 Kangle Guardian Company Information
  9. 8.2.2 Kangle Guardian Business Overview
  10. 8.2.3 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  12. 8.2.5 Kangle Guardian Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck HPV Vaccine for Men(Male HPV Vaccine) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Wantai Biotech
  20. 8.4.1 Wantai Biotech Company Information
  21. 8.4.2 Wantai Biotech Business Overview
  22. 8.4.3 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  24. 8.4.5 Wantai Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 HPV Vaccine for Men(Male HPV Vaccine) Value Chain Analysis
  2. 9.1.1 HPV Vaccine for Men(Male HPV Vaccine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 HPV Vaccine for Men(Male HPV Vaccine) Sales Mode & Process
  6. 9.2 HPV Vaccine for Men(Male HPV Vaccine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 HPV Vaccine for Men(Male HPV Vaccine) Distributors
  9. 9.2.3 HPV Vaccine for Men(Male HPV Vaccine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst